Benchmark of the PenRed Monte Carlo framework for HDR brachytherapy

dc.contributor.authorOliver Gil, Sandra
dc.contributor.authorGiménez Alventosa, Vicent
dc.contributor.authorBerumen Murillo, Francisco
dc.contributor.authorGiménez Gómez, Vicent
dc.contributor.authorBeaulieu, Luc
dc.contributor.authorBallester Pallarés, Facundo
dc.contributor.authorVijande Asenjo, Javier
dc.date.accessioned2023-03-29T12:33:28Z
dc.date.available2023-03-29T12:33:28Z
dc.date.issued2023
dc.description.abstractThe purpose of this study is to validate the PenRed Monte Carlo framework for clinical applications in brachytherapy. PenRed is a C++ version of Penelope Monte Carlo code with additional tallies and utilities. Six benchmarking scenarios are explored to validate the use of PenRed and its improved bachytherapy-oriented capabilities for HDR brachytherapy. A new tally allowing the evaluation of collisional kerma for any material using the track length kerma estimator and the possibility to obtain the seed positions, weights and directions processing directly the DICOM file are now implemented in the PenRed distribution. The four non-clinical test cases developed by the Joint AAPM-ESTRO-ABG-ABS WG-DCAB were evaluated by comparing local and global absorbed dose differences with respect to established reference datasets. A prostate and a palliative lung cases, were also studied. For them, absorbed dose ratios, global absorbed dose differences, and cumulative dose-volume histograms were obtained and discussed.spa
dc.description.filiationUEVspa
dc.description.impact2.4 Q2 JCR 2023spa
dc.description.impact0.488 Q2 SJR 2023spa
dc.description.impactNo data IDR 2023spa
dc.description.sponsorshipMinisterio de Ciencia e Innovación of Spain (MCIN) (MCIN/AEI/10.13039/501100011033) (PID2020-113126RB-I00, PID2021-125096NB-I00)spa
dc.description.sponsorshipAEI-MICINN (PID2020-113334GB-I00/AEI/10.13039/501100011033)spa
dc.description.sponsorshipGeneralitat Valenciana (PROMETEO/2019/087)spa
dc.description.sponsorshipNatural Sciences and Engineering Research Council of Canada (NSERC) (RGPIN-2019-05038)spa
dc.description.sponsorshipFonds de Recherche du Québec – Nature et Technologies (FRQNT) (MCIN/AEI/10.13039)spa
dc.description.sponsorshipGeneralitat Valenciana (GVA) (PROMETEO/2021/064)spa
dc.identifier.citationOliver, S., Giménez-Alventosa, V., Berumen, F., Gimenez, V., Beaulieu, L., Ballester, F., & Vijande, J. (2023). Benchmark of the penred monte carlo framework for hdr brachytherapy. Zeitschrift Für Medizinische Physik, 33(4), 511-528. https://doi.org/10.1016/j.zemedi.2022.11.002spa
dc.identifier.doi10.1016/j.zemedi.2022.11.002
dc.identifier.issn0939-3889
dc.identifier.issn1876-4436
dc.identifier.urihttp://hdl.handle.net/11268/11969
dc.language.isoengspa
dc.peerreviewedSispa
dc.relation.publisherversionhttps://doi.org/10.1016/j.zemedi.2022.11.002spa
dc.rights.accessRightsopen accessspa
dc.subject.otherBraquiterapiaspa
dc.subject.unescoCáncerspa
dc.subject.unescoTratamiento médicospa
dc.subject.unescoModelo de simulaciónspa
dc.titleBenchmark of the PenRed Monte Carlo framework for HDR brachytherapyspa
dc.typejournal articlespa
dspace.entity.typePublication

Files